These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15060754)

  • 1. Is 11C-choline the most appropriate tracer for prostate cancer? Against.
    Zöphel K; Kotzerke J
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):756-9. PubMed ID: 15060754
    [No Abstract]   [Full Text] [Related]  

  • 2. Is 11C-choline the most appropriate tracer for prostate cancer? For.
    Fazio F; Picchio M; Messa C
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):753-6. PubMed ID: 15060753
    [No Abstract]   [Full Text] [Related]  

  • 3. 11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
    Nanni C; Castellucci P; Farsad M; Rubello D; Fanti S
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1704-5. PubMed ID: 17619877
    [No Abstract]   [Full Text] [Related]  

  • 4. [First experience of using positron emission tomography with 11C-choline in prostate cancer (PC)].
    Granov AM; Tiutin LA; Ryzhkova DV; Shkol'nik MI; Andabekov TT; Mostova MI; Shatik SV; Kostenikov NA; Zaĭtsev VV; Tlostanova MS; Stanzhevskiĭ AA; Panfilenko AA; Arzumanov AA; Metelëv VV; Iliushchenko IuR
    Vopr Onkol; 2013; 59(4):460-4. PubMed ID: 24032219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide.
    Murphy RC; Kawashima A; Peller PJ
    AJR Am J Roentgenol; 2011 Jun; 196(6):1390-8. PubMed ID: 21606304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [11C]choline PET for the intraprostatic tumor characterization and localization in recurrent prostate cancer after EBRT.
    Rybalov M; Breeuwsma AJ; Pruim J; Leliveld AM; Rosati S; Veltman NC; Dierckx RA; De Jong IJ
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):202-8. PubMed ID: 22402821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging prostate cancer with 11C-choline PET/CT.
    Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
    J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of PET/CT and current challenges in prostate cancer management.
    Lindholm P; Seppänen M; Minn H
    Nucl Med Commun; 2009 May; 30(5):325. PubMed ID: 19421025
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
    Greco C; Cascini GL; Tamburrini O
    Prostate Cancer Prostatic Dis; 2008; 11(2):121-8. PubMed ID: 18180806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
    Sutinen E; Nurmi M; Roivainen A; Varpula M; Tolvanen T; Lehikoinen P; Minn H
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):317-24. PubMed ID: 14628097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
    Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
    BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: 11C-choline-positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Chun FK
    Eur Urol; 2008 Aug; 54(2):400-1. PubMed ID: 18456392
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer.
    Scher B; Seitz M; Albinger W; Tiling R; Scherr M; Becker HC; Souvatzogluou M; Gildehaus FJ; Wester HJ; Dresel S
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):45-53. PubMed ID: 16932935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
    Garcia JR; Jorcano S; Soler M; Linero D; Moragas M; Riera E; Miralbell R; Lomeña F
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):342-50. PubMed ID: 24844254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pro and contra: 11C choline PET in diagnosis of prostate cancer].
    Kotzerke J; Zöphel K; Salomon G; Graefen M; Heidenreich A
    Aktuelle Urol; 2007 May; 38(3):189-94. PubMed ID: 17566231
    [No Abstract]   [Full Text] [Related]  

  • 16. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
    Reske SN; Moritz S; Kull T
    Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):430-9. PubMed ID: 23069922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low diagnostic yield of the 11C-choline PET/CT in the detection of liver metastasis from prostate cancer].
    García JR; Franquet E; Romera N; Moragas M; Jorcano S; Moragas G
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):56-7. PubMed ID: 24125594
    [No Abstract]   [Full Text] [Related]  

  • 18. 11C-acetate positron emission tomography for occult prostate cancer.
    Froehner M; Beuthien-Baumann B; Wirth MP
    Urol Oncol; 2006; 24(5):410-1. PubMed ID: 16962491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.